ArticleThe Egyptian rheumatologist2021

Six month assessment of low dose rituximab in the treatment of rheumatoid arthritis during coronavirus disease 2019 (COVID-19) pandemic.

Yunus Durmaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.